Association between serum level soluble programmed cell death ligand 1 and prognosis in patients with non‐small cell lung cancer treated with anti‐PD‐1 antibody

BACKGROUND: Programmed cell death ligand 1 (PD‐L1) is known to have soluble forms aside from its membrane‐bound forms. The aim of this study was to evaluate the predictive and prognostic values of serum soluble PD‐L1 (sPD‐L1) in patients with non‐small cell lung cancer (NSCLC) who were treated with...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Thorac Cancer
Main Authors: Murakami, Shuji, Shibaki, Ryota, Matsumoto, Yuji, Yoshida, Tatsuya, Goto, Yasushi, Kanda, Shintaro, Horinouchi, Hidehito, Fujiwara, Yutaka, Yamamoto, Noboru, Ohe, Yuichiro
פורמט: Artigo
שפה:Inglês
יצא לאור: John Wiley & Sons Australia, Ltd 2020
נושאים:
Original Articles
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7705908/
https://ncbi.nlm.nih.gov/pubmed/33108686
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13721
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים